These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9477171)

  • 1. Characteristic subcellular distribution, in brain, heart and lung, of biperiden, trihexyphenidyl, and (-)-quinuclidinyl benzylate in rats.
    Ishizaki J; Yokogawa K; Nakashima E; Ohkuma S; Ichimura F
    Biol Pharm Bull; 1998 Jan; 21(1):67-71. PubMed ID: 9477171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor.
    Kimura Y; Ohue M; Kitaura T; Kihira K
    Brain Res; 1999 Jul; 834(1-2):6-12. PubMed ID: 10407088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sequence of administration on the pharmacokinetic interaction between the anticholinergic drug biperiden and [3H]quinuclidinyl benzylate or [3H]N-methylscopolamine in rats.
    Ishizaki J; Yokogawa K; Nakashima E; Takayasu T; Ohshima T; Ichimura F
    J Pharm Pharmacol; 1998 Feb; 50(2):189-96. PubMed ID: 9530987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiparkinsonian drugs on muscarinic receptor binding in rat brain, heart and lung.
    Syvälahti EK; Kunelius R; Laurén L
    Pharmacol Toxicol; 1988 Feb; 62(2):90-4. PubMed ID: 3353357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ammonium chloride on the tissue distribution of anticholinergic drugs in rats.
    Ishizaki J; Yokogawa K; Nakashima E; Ohkuma S; Ichimura F
    J Pharm Pharmacol; 1998 Jul; 50(7):761-6. PubMed ID: 9720625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of anticholinergic drugs and brain muscarinic receptor alterations in streptozotocin diabetic rats.
    Nakashima E; Ishizaki J; Takeda M; Matsushita R; Yokogawa K; Ichimura F
    Biopharm Drug Dispos; 1993 Nov; 14(8):673-84. PubMed ID: 8305628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain.
    Katayama S; Ishizaki F; Yamamura Y; Khoriyama T; Kito S
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):261-70. PubMed ID: 2236897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct, divalent cation-sensitive, antagonist binding states of heart muscarinic receptors: differential modulation by guanine nucleotide.
    Sulakhe PV; Jagadeesh G; Phan NT
    Gen Pharmacol; 1990; 21(2):211-8. PubMed ID: 2110087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vivo binding properties of 3H-NMPB and 3H-QNB in mouse brain.
    Hosoi R; Kobayashi K; Watanabe Y; Inoue O
    J Neural Transm (Vienna); 1999; 106(7-8):583-92. PubMed ID: 10907719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart.
    Larson EW; Pfenning MA; Richelson E
    Psychopharmacology (Berl); 1991; 103(2):162-5. PubMed ID: 2027917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of the anticholinergic drugs trihexyphenidyl and biperiden on the plasma concentrations of bromperidol and its reduced metabolite.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Kaneko S; Inoue Y; Shibata M; Ikeda K
    Ther Drug Monit; 1997 Apr; 19(2):165-8. PubMed ID: 9108644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
    Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
    Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physiologically based pharmacokinetic model for (-)-quinuclidinyl benzylate using nonlinear irreversible tissue binding parameters in rats.
    Ishizaki J; Nakashima E; Yokogawa K; Nagano T; Takayasu T; Ichimura F
    Drug Metab Dispos; 1992; 20(4):485-9. PubMed ID: 1356722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicyclomine, benzhexol and oxybutynine distinguish between subclasses of muscarinic binding sites.
    Nilvebrant L; Sparf B
    Eur J Pharmacol; 1986 Apr; 123(1):133-43. PubMed ID: 3754815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effect of methyl-quinuclidinyl-benzylate on myocardial beta-adrenoceptor density.
    Valette H; Syrota A; Fuseau C; Brutesco C
    Eur J Pharmacol; 1996 Jun; 306(1-3):133-8. PubMed ID: 8813625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic cholinergic receptors in developing rat lung.
    Whitsett JA; Hollinger B
    Pediatr Res; 1984 Nov; 18(11):1136-40. PubMed ID: 6514439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 125I-labeled binding probe for the muscarinic cholinergic receptor.
    Flanagan SD; Storni A
    Brain Res; 1979 May; 168(2):261-74. PubMed ID: 445143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment, solubilization, and partial characterization of digitonin-solubilized muscarinic receptors derived from canine ventricular myocardium.
    Manalan AS; Werth DK; Jones LR; Watanabe AM
    Circ Res; 1983 Jun; 52(6):664-76. PubMed ID: 6305530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
    Nilvebrant L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.